RankAlpha logo
Back to Rankings

ARGX

argenx SEA
Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-06-02
View Chart
+
Peers tracked
10
U.S. public peers
Grade Position
Above peers
vs peer average
ARGX vs peer average
72/100
ARGX vs. peer average (A vs. B)
Grade spread
A 2 · B 3 · C 4 · D 1
Graded peers loaded
Coverage
10 graded
100% of tracked

Peer overview

GEN is the first available peer comparator.

Genmab — antibody-focused R&D and partnered commercialization, comparable biologics-driven upside profile.

✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
Top peerGENGen Digital
ARGX
argenx SE
GEN
Gen Digital
Grade
A
B
Momentum
70
89
Value
54
64
Sentiment
-
25
Setup Bias
Net Neutral
-
Market Cap
-
-
Posture
Constructive
Constructive
Open Side-by-Side ComparisonCompare all

Grade position vs GEN

ARGX / GEN
Grade Position
Above peers
ARGX vs. peer average (A vs. B)
72/100
Momentum
70
GEN
Value
54
GEN
Sentiment
-
-

Rotation landscape

Peers ranked by the order returned from the peer source, with grades from the API.

Rank
Ticker
Company
Grade
Grade score
vs ARGX
1
GEN
GEN
B
80/100
+1
2
REGN
REGN
C
60/100
+2
3
UCB
UCB
C
60/100
+2
4
TAK
Takeda Pharmaceutical Co Ltd ADR
C
60/100
+2
5
TEVA
Teva Pharmaceutical Industries Ltd ADR
A
100/100
Even
GEN is the first peer returned for this comparison set.